← Back to Clinical Trials
Recruiting NCT06687278

NCT06687278 Effectiveness of Interpersonal Relationship Psychotherapy Intervention for Female Victims of Intimate Partner Violence

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06687278
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Intimate Partner Violence (IPV)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-02-03
Primary Completion 2025-05

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Interpersonal Relationship Psychotherapy-Based Intervention Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-02-03 with a primary completion date of 2025-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This interventional study aims to examine the impact of the Interpersonal Relationship Psychotherapy-Based Intervention Program on the psychosocial well-being of female victims of intimate partner violence. The main questions to be answered are the following: 1. Is the Interpersonal Relationship Psychotherapy-Based Intervention Program effective on the interpersonal problems of female victims of intimate partner violence? 2. Is the Interpersonal Relationship Psychotherapy-Based Intervention Program effective on the mental well-being of female victims of intimate partner violence? The study will include eight individual interviews using a variety of data collection forms.

Eligibility Criteria

Inclusion Criteria: * Proficiency in the Turkish language, including the ability to speak and understand it. * Exposure to any form of violence perpetrated by an intimate partner. Exclusion Criteria: * Exposure to violence by an individual other than an intimate partner for the purpose of maintaining group homogeneity. * Presence of sensory loss, including but not limited to hearing and vision. * Physical injury and/or disability resulting from violence that precludes participation in the intervention program. * Diagnosis of schizophrenia spectrum disorders and other psychotic disorders. * Presence of active self-destructive thoughts and/or plans.

Contact & Investigator

Central Contact

Cennet Kara Özçalık

✉ cennetkaraozcalik@gmail.com

📞 +9005078267597

Principal Investigator

Cennet Kara Özçalık

PRINCIPAL INVESTIGATOR

Istanbul Universty-Cerrahpasa

Frequently Asked Questions

Who can join the NCT06687278 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Intimate Partner Violence (IPV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06687278 currently recruiting?

Yes, NCT06687278 is actively recruiting participants. Contact the research team at cennetkaraozcalik@gmail.com for enrollment information.

Where is the NCT06687278 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06687278 clinical trial?

NCT06687278 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Cennet Kara Özçalık at Istanbul Universty-Cerrahpasa. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology